Details for Patent: 10,738,037
✉ Email this page to a colleague
Which drugs does patent 10,738,037 protect, and when does it expire?
Patent 10,738,037 protects ROZLYTREK and is included in one NDA.
This patent has nineteen patent family members in thirteen countries.
Summary for Patent: 10,738,037
| Title: | Crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide |
| Abstract: | The present invention relates to a new crystalline form of N-[5-(3,5-difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide, process for its preparation, its utility in treating diseases caused by deregulated protein kinase activity and pharmaceutical compositions containing it. |
| Inventor(s): | Ilaria Candiani, Giovanni OTTAIANO, Attilio Tomasi |
| Assignee: | Nerviano Medical Sciences SRL |
| Application Number: | US16/301,826 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 10,738,037
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | ROZLYTREK | entrectinib | CAPSULE;ORAL | 212725-001 | Aug 15, 2019 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | TREATMENT OF COLORECTAL CANCER THAT HAS A NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSION | ⤷ Start Trial | ||
| Genentech Inc | ROZLYTREK | entrectinib | CAPSULE;ORAL | 212725-002 | Aug 15, 2019 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | TREATMENT OF COLORECTAL CANCER THAT HAS A NEUROTROPHIC TYROSINE RECEPTOR KINASE (NTRK) GENE FUSION | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,738,037
| PCT Information | |||
| PCT Filed | May 18, 2017 | PCT Application Number: | PCT/EP2017/061919 |
| PCT Publication Date: | November 30, 2017 | PCT Publication Number: | WO2017/202674 |
International Family Members for US Patent 10,738,037
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017271458 | ⤷ Start Trial | |||
| Brazil | 112018073951 | ⤷ Start Trial | |||
| Canada | 3024208 | ⤷ Start Trial | |||
| China | 109153669 | ⤷ Start Trial | |||
| European Patent Office | 3464276 | ⤷ Start Trial | |||
| European Patent Office | 3967689 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
